Login to Your Account

Financings Roundup

European IPO Window Open? Philogen Files $89.6M Offering

By Jennifer Boggs

Thursday, February 10, 2011
If the three initial public offerings to price late last week – Pacira Pharmaceuticals Inc., Endocyte Inc. and BG Medicine Inc. – are a promising sign for the U.S. IPO market, then perhaps Italian biotech Philogen SpA's plans for a €65.3 million (US$89.6 million) offering on the Milan stock exchange is a signal the European markets are opening up as well.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription